 | Up a level |
Nilius, Henning; Hamzeh-Cognasse, Hind; Hastings, Janna; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Greinacher, Andreas; Mendez, Adriana; Schmidt, Adrian Emanuel; Wuillemin, Walter A; Gerber, Bernhard; Vishnu, Prakash; Graf, Lukas; Kremer Hovinga, Johanna A; Bakchoul, Tamam; Cognasse, Fabrice; Nagler, Michael (2024). Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. (In Press). Blood advances American Society of Hematology 10.1182/bloodadvances.2024012782
Larsen, Emil List; Nilius, Henning; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Greinacher, Andreas; Mendez, Adriana; Schmidt, Adrian; Wuillemin, Walter A; Gerber, Bernhard; Vishnu, Prakash; Graf, Lukas; Kremer Hovinga, Johanna A; Goetze, Jens P; Bakchoul, Tamam; Nagler, Michael (2024). Accuracy of Diagnosing Heparin-Induced Thrombocytopenia. JAMA Network Open, 7(3) American Medical Association 10.1001/jamanetworkopen.2024.3786
Schimmer, Roman R; Sutter, Tabea; Bachofner, Adrian; Ranieri, Elisabetta; Rodewald, Ann-Kathrin; Kremer Hovinga, Johanna A; Kimmich, Nina; Trinchero, Alice; Studt, Jan-Dirk (2024). Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab. (In Press). British journal of haematology Wiley-Blackwell 10.1111/bjh.19284
Hammerer-Lercher, Angelika; Nilius, Henning; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Greinacher, Andreas; Mendez, Adriana; Schmidt, Adrian; Wuillemin, Walter A; Gerber, Bernhard; Kremer Hovinga, Johanna A; Vishnu, Prakash; Graf, Lukas; Bakchoul, Tamam; Nagler, Michael (2023). Limited concordance of heparin/PF4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study. Journal of thrombosis and haemostasis, 21(9), pp. 2559-2568. Wiley-Blackwell 10.1016/j.jtha.2023.05.016
Angelillo, Anne; Casini, Alessandro; Studt, Jan-Dirk; Gerber, Bernhard; Alberio, Lorenzo A; Fontana, Pierre (2023). Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland. Swiss medical weekly, 153(40113), p. 40113. EMH Schweizerischer Ärzteverlag 10.57187/smw.2023.40113
Burger, Annika; Studt, Jan-Dirk; Mendez, Adriana; Alberio, Lorenzo; Fontana, Pierre; Wuillemin, Walter A; Schmidt, Adrian; Graf, Lukas; Gerber, Bernhard; Bovet, Cédric; Sauter, Thomas C; Binder, Nikolaus B; Nagler, Michael (2023). Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator. Diagnostics, 13(12) MDPI 10.3390/diagnostics13122128
Nilius, Henning; Cuker, Adam; Haug, Sigve; Nakas, Christos; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Greinacher, Andreas; Mendez, Adriana; Schmidt, Adrian; Wuillemin, Walter A; Gerber, Bernhard; Kremer, Johanna A; Vishnu, Prakash; Graf, Lukas; Kashev, Alexander; Sznitman, Raphael; Bakchoul, Tamam; Nagler, Michael (2023). A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study. EClinicalMedicine, 55, p. 101745. Elsevier 10.1016/j.eclinm.2022.101745
Sathanantham, Vepusha; Alberio, Lorenzo; Bovet, Cédric; Fontana, Pierre; Gerber, Bernhard; Graf, Lukas; Mendez, Adriana; Sauter, Thomas C; Schmidt, Adrian; Studt, Jan-Dirk; Wuillemin, Walter A; Nagler, Michael (2022). Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study. Life, 12(7) MDPI 10.3390/life12071027
Meihandoest, Tamana; Studt, Jan-Dirk; Mendez, Adriana; Alberio, Lorenzo; Fontana, Pierre; Wuillemin, Walter A; Schmidt, Adrian; Graf, Lukas; Gerber, Bernhard; Amstutz, Ursula; Bovet, Cedric; Sauter, Thomas C; Asmis, Lars M; Nagler, Michael (2022). Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study. Frontiers in cardiovascular medicine, 9, p. 817826. Frontiers 10.3389/fcvm.2022.817826
Van den Berg, Jana; Kremer Hovinga, Johanna A.; Pfleger, Claudia; Hegemann, Inga; Stehle, Gregor Thomas; Holbro, Andreas; Studt, Jan-Dirk (2022). Daratumumab for immune thrombotic thrombocytopenic purpura. Blood advances, 6(3), pp. 993-997. American Society of Hematology 10.1182/bloodadvances.2021005124
Willekens, Guido; Studt, Jan-Dirk; Mendez, Adriana; Alberio, Lorenzo; Fontana, Pierre; Wuillemin, Walter A; Schmidt, Adrian; Graf, Lukas; Gerber, Bernhard; Bovet, Cedric; Sauter, Thomas C; Nagler, Michael (2021). A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation. British journal of haematology, 193(6), pp. 1203-1212. Wiley-Blackwell 10.1111/bjh.17470
Brodard, Justine; Kremer Hovinga, Johanna A.; Fontana, Pierre; Studt, Jan-Dirk; Gruel, Yves; Greinacher, Andreas (2021). COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies. Journal of thrombosis and haemostasis, 19(5), pp. 1294-1298. Wiley-Blackwell 10.1111/jth.15262
Meihandoest, Tamana; Studt, Jan-Dirk; Mendez, Adriana; Alberio, Lorenzo; Fontana, Pierre; Wuillemin, Walter A; Schmidt, Adrian; Graf, Lukas; Gerber, Bernhard; Maeder, Gabriela Monika; Bovet, Cédric; Sauter, Thomas C; Nagler, Michael (2021). Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements. Frontiers in cardiovascular medicine, 8, p. 717939. 10.3389/fcvm.2021.717939
Nagler, Michael; Asmis, Lars M.; Gerber, Bernhard; Ruosch, Sabine; Spirk, David; Surbek, Daniel; Studt, Jan-Dirk; Tsakiris, Dimitrios A.; Wuillemin, Walter A. (2021). Venöse Thromboembolie in Gynäkologie und Geburtshilfe. Swiss Medical Forum, 21(29-30), pp. 503-508. EMH Swiss Medical Publishers 10.4414/smf.2021.08773
Fontana, Pierre; Alberio, Lorenzo; Albisetti, Manuela; Angelillo, Anne; Asmis, Lars M; Casini, Alessandro; Gerber, Bernhard; Graf, Lukas; Hegemann, Inga; Korte, Wolfgang; Martinez, Maria; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Wuillemin, Walter A; Kremer Hovinga, Johanna A. (2020). Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab. Swiss medical weekly, 150, w20422. EMH Schweizerischer Ärzteverlag 10.4414/smw.2020.20422
Alberio, Lorenzo A.; Angelillo-Scherrer, Anne; Asmis, Lars M.; Casini, Alessandro; Fontana, Pierre; Graf, Lukas; Hegemann, Inga; Kremer Hovinga, Johanna A.; Korte, Wolfgang; Lecompte, Thomas; Martinez, Martina; Nagler, Michael; Studt, Jan-Dirk; Tsakiris, Dimitrios A.; Wuillemin, Walter A. (2020). Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland. Swiss medical weekly, 150(w20210), w20210. EMH Media 10.4414/smw.2020.20210
Casini, Alessandro; Alberio, Lorenzo; Angelillo-Scherrer, Anne; Fontana, Pierre; Gerber, Bernhard; Graf, Lukas; Hegemann, Inga; Korte, Wolfgang; Kremer Hovinga, Johanna A.; Lecompte, Thomas; Martinez, Maria; Nagler, Michael; Studt, Jan-Dirk; Tsakiris, Dimitrios; Wuillemin, Walter; Asmis, Lars (2020). Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis. Swiss medical weekly, 150(w20247), w20247. EMH Media 10.4414/smw.2020.20247
Fontana, Pierre; Alberio, Lorenzo; Angelillo-Scherrer, Anne; Asmis, Lars M; Korte, Wolfgang; Mendez, Adriana; Schmid, Pirmin; Stricker, Hans; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Wuillemin, Walter A; Nagler, Michael (2017). Impact of rivaroxaban on point-of-care assays. Thrombosis research, 153, pp. 65-70. Elsevier 10.1016/j.thromres.2017.03.019
